PPARG and neoplasm: More recently, however, PPARG antagonism was successfully used to halt the in vitro growth of tumor cells of various sources [e.g., breast (Yuan et al, 2012; Wang et al, 2013), esophagus (Takahashi et al, 2006), and pancreas (Nakajima et al, 2008)].